Department of Internal Medicine, Hospital of Navarra, Pamplona, Navarra, Spain.
Eur J Gastroenterol Hepatol. 2010 May;22(5):513-8. doi: 10.1097/MEG.0b013e328335b2b2.
To evaluate the effect of smoking on the hemodynamic status of liver cirrhosis and several vasoactive substances.
Hemodynamic, blood gases values, liver parameters, and several vasopressors and vasodilators substances were measured in consecutive inpatients diagnosed of liver cirrhosis divided into two groups: smokers and nonsmokers.
Nineteen smoking cirrhotic patients and 13 nonsmoking cirrhotic patients were studied. Both groups showed similar age, Child--Pugh and model for end-stage liver disease indexes. Smokers had higher levels of hemoglobin and lower partial pressure of arterial oxygen, FEV1/FVC %, cardiac output and total vascular resistance than nonsmokers. Plasma level of adrenomedullin was independently higher in nonsmoking cirrhotic patients than in smokers.
In contrast with smoking cirrhotic patients, nonsmoking cirrhotic patients show an increased systemic vasodilation, which could depend on higher plasmatic levels of adrenomedullin.
评估吸烟对肝硬化患者血流动力学状态和几种血管活性物质的影响。
连续收治的肝硬化住院患者被分为两组:吸烟者和非吸烟者,分别测量其血流动力学、血气值、肝功能参数以及几种血管加压素和血管扩张剂物质。
研究共纳入 19 名吸烟肝硬化患者和 13 名非吸烟肝硬化患者。两组患者的年龄、Child-Pugh 分级和终末期肝病模型评分相似。与非吸烟者相比,吸烟者的血红蛋白水平较高,动脉血氧分压、FEV1/FVC%、心输出量和总血管阻力较低。血浆肾上腺髓质素水平在非吸烟者肝硬化患者中独立高于吸烟者。
与吸烟肝硬化患者相比,非吸烟肝硬化患者表现出全身性血管舒张增加,这可能依赖于较高的血浆肾上腺髓质素水平。